1. Home
  2. BHVN vs SPRY Comparison

BHVN vs SPRY Comparison

Compare BHVN & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$10.61

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$9.09

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
SPRY
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.0B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
BHVN
SPRY
Price
$10.61
$9.09
Analyst Decision
Buy
Strong Buy
Analyst Count
14
2
Target Price
$27.69
$35.00
AVG Volume (30 Days)
1.9M
887.0K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
26.08
114.04
EPS
N/A
N/A
Revenue
N/A
$89,149,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$119.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
297063.34
52 Week Low
$7.48
$6.66
52 Week High
$31.80
$18.63

Technical Indicators

Market Signals
Indicator
BHVN
SPRY
Relative Strength Index (RSI) 40.76 42.41
Support Level $8.40 $8.61
Resistance Level $11.92 $10.44
Average True Range (ATR) 0.64 0.48
MACD -0.10 0.01
Stochastic Oscillator 23.95 46.60

Price Performance

Historical Comparison
BHVN
SPRY

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: